C. E. Gutteridge, J. V. Vo, C. B. Tillett, J. A. Vigilante, J. R. Dettmer, S. L. Patterson, K. A. Werbovetz, J. Capers, D. A. Nichols, A. K. Bhattacharjee and L. Gerena Pages 115 - 119 ( 5 )
The antileishmanial and antimalarial activity of methoxy-substituted chalcones (1,3-diphenyl-2-propen-1-ones) is well established. The few analogs prepared to date where the 3-phenyl group is replaced by either a pyridine or naphthalene suggest these modifications are potency enhancing. To explore this hypothesis, sixteen 3-naphthalenyl-1-phenyl- 2-prop-1-enones and ten 1-phenyl-3-pyridinyl-2-prop-1-enones were synthesized and their in vitro efficacies against Leishmania donovani and Plasmodium falciparum determined. One inhibitor with submicromolar efficacy against L. donovani was identified (IC50 = 0.95 μM), along with three other potent compounds (IC50 < 5 μM), all of which were 3- pyridin-2-yl derivatives. No inhibitors with submicromolar efficacy against P. falciparum were identified, though several potent compounds were found (IC50 < 5 μM). The cytotoxicity of the five most active L. donovani inhibitors was assessed. At best the IC50 against a primary kidney cell line was around two-fold higher than against L. donovani. Being more active than pentamidine, the 1-phenyl-3-pyridin-2-yl-2-propen-1-ones have potential for further development against leishmaniasis; however it will be essential in such a program to address not only efficacy but also their potential for toxicity.
Leishmaniasis, malaria, chalcone, propenone, structure activity relationship, cytotoxicity
572M Holloway Road, Mailstop 9B, United States Naval Academy, Annapolis, MD 21402, USA.